MoCRA for cosmetics in the US: which data product development and regulatory teams need to organize
The Modernization of Cosmetics Regulation Act of 2022 significantly expanded FDA authority over cosmetics. For companies serving the US market, facility registration, product listing and other requirements can be relevant. R&D and product data should therefore support US-specific workflows rather than being reconstructed only at export stage.
In short: what changed under MoCRA?
MoCRA introduced new FDA authorities and requirements. According to FDA information, certain manufacturers and processors must register facilities and renew every two years; a responsible person must list each marketed cosmetic product and update product information regularly. Exemptions and additional product-specific requirements apply.
Key takeaways
- Model US market requirements separately
- Keep product and ingredient data consistent for listings
- Separate facility and responsible-person data
- Plan changes and annual updates operationally
- Distinguish FDA guidance from statutory requirements
See it with your own data
In 30 minutes we walk you through the workflow using your formulas and raw materials. No obligation, reply within one business day.
Facility Registration and Product Listing
FDA describes two central MoCRA processes: registration of certain manufacturing and processing facilities with biennial renewal, and product listing by the responsible person for marketed cosmetics including ingredient information and annual updates. Certain small businesses and product types may be exempt.
Why product data needs structure
Listings, safety and labelling workflows depend on product identity, ingredients, manufacturer/processor information and responsible-person data. Maintaining these across disconnected files increases the risk of inconsistent submissions.
Cosmetics Direct as the operational portal
FDA provides Cosmetics Direct for electronic facility registration and product listing. The portal was updated in 2026 for biennial facility renewal workflows. Internal product approval and portal submission should remain clearly separated.
Do not collapse EU and US compliance into one status
EU and US frameworks use different roles, procedures and data requirements. A global R&D system should model market requirements separately while sharing the same approved product and raw-material foundation.
MoCRA data area and internal relationship
| Facility Registration | Manufacturer/processor location |
| Product Listing | Product + ingredient information |
| Responsible Person | Manufacturer/packer/distributor under US definition |
| Updates | Change and release process |
| Portal | Cosmetics Direct / FDA submission |
Frequently asked questions
Sources
Disclaimer: This article is for general information only. It is not legal advice and not a regulatory or safety assessment of any individual case. We prepare the content carefully but give no warranty as to its accuracy, completeness or currency; legislation and standards may change after the date stated. Only the officially published text is binding. Make decisions about your products with qualified support, such as your safety assessor or legal adviser. We are liable for damage arising from the use of this information only in cases of intent and gross negligence; liability for injury to life, body or health and under mandatory statutory provisions remains unaffected.
Related articles
Regulatory & compliance